FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 2111649 · Received June 2, 2011

Report

Report Number
1823260-2011-02946
Event Type
Malfunction
Date Received
June 2, 2011
Date of Event
May 20, 2011
Report Date
August 11, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

CALLER STATES HE TESTED 4.0 INR ON THE COAGUCHEK XS SYSTEM AND 3.0 INR ON A COMPARISON LAB. NO ACTIONS WERE REPORTED TAKEN OR TREATMENT RECEIVED. NO ADVERSE EVENT REPORTED. A REQUEST WAS MADE FOR THE RETURN OF THE AFFECTED PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 20306222

Patients

Seq Age Sex Outcome Treatment
1 066 YR COUMADIN| PACEMAKER| OMEGA 3 FISH OIL| FIBER| "TAMAZAPINE"| TRICOR| LANOXIN| POTASSIUM CHLORIDE| TOPROL| REMERON| WELLBUTRIN| LASIX| VYTORIN| INSPRA